The University of Rhode Island Doctor of Pharmacy program is accredited by the Accreditation Council for Pharmacy Education.
Three Ph.D. students at the University of Rhode Island’s College of Pharmacy have started a company that harnesses big data in a novel approach to drug development.
When Iman Aberra first visited URI as a high school student from New Jersey, she fell in love with the campus and the welcoming atmosphere at the College of Pharmacy. Those first impressions proved prescient, as Aberra found in URI a community that afforded her ample opportunities to grow academically and personally.
Jennifer Bairam, a junior in the University of Rhode Island’s Bachelor of Science in Pharmaceutical Sciences (BSPS) program, had been eager to get real-world exposure to potential career paths in the pharmaceutical industry.
Bingfang Yan, professor of biomedical and pharmaceutical sciences, has made his reputation identifying adverse reactions among prescription medications. His studies often examine drugs that hit the marketplace as much-needed therapeutic breakthroughs and their interactions with medications typically prescribed along with them.
Susan Johnson, an alumna of the College of Pharmacy, made her mark on health care nationally when she pioneered hospital clinics for patients taking anti-coagulant drugs. Providing on-site, instant blood test results brought more precise dosing of these tricky-to-manage anti-clotting drugs and helped to reduce patient hospitalizations.
The Champlin Foundations, one of the oldest philanthropic organizations in Rhode Island, has awarded the University of Rhode Island five grants totaling $602,580. These funds support educational tools and technologies in communications, engineering, pharmacy and health sciences, significantly enhancing student engagement and bolstering a broad spectrum of programs at URI.
The van Beuren Charitable Foundation has renewed funding for at-home pharmacist care implemented by the University of Rhode Island’s College of Pharmacy/Academic Health Collaborative in conjunction with Visiting Nurse Services of Newport and Bristol Counties.
Hepatitis C and HIV medications can be adversely interacted when used together, URI pharmacy professor reports
In the past few years, the normally reticent scientific community heralded as revolutionary new medications for Hepatitis C, saying the drugs would bring a major shift in the treatment of the chronic and potentially fatal viral infection that affects 150 million people worldwide.
The generation gap is shrinking one mouse click at a time, and the University of Rhode Island is helping to close it. In fall 2015 faculty from the Colleges of Health Sciences, Pharmacy and Arts and Sciences launched the URI Engaging Generations: Cyber-Seniors Program, an offshoot of an initiative started by teenage sisters in Canada in 2009 that has expanded […]
Antibiotics are one of the most significant scientific developments of the 20th century. They have made infections that were once fatal routinely treatable, while also allowing for other medical advances, like cancer chemotherapy and organ transplants, because antibiotics can treat a serious infection if it occurs.
Copyright © 2017 University of Rhode Island.